Gene amplification in cancer

Trends in Genetics

Volumn 22, Issue 8, 2006, Pages 447-455

  Albertson, Donna G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GENETICS; CANCER RISK; CHROMOSOME ARM; CHROMOSOME FRAGILE SITE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA REPLICATION; GENE AMPLIFICATION; GENE FUNCTION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; IN SITU HYBRIDIZATION; KARYOTYPING; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; TELOMERE;

CELL LINE, TUMOR; CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN; DNA REPLICATION; GENE AMPLIFICATION; HUMANS; NEOPLASMS; ONCOGENES; PHENOTYPE; TELOMERE;

EID: 33746255899     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2006.06.007     Document Type: Review

References (84)

1. Albertson D.G., et al. Chromosome aberrations in solid tumors. Nat. Genet. 34 (2003) 369-376
2. Tower J. Developmental gene amplification and origin regulation. Annu. Rev. Genet. 38 (2004) 273-304
3. Stark G.R., and Wahl G.M. Gene amplification. Annu. Rev. Biochem. 53 (1984) 447-491
4. Tlsty T.D. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3132-3136
5. Wright J.A., et al. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1791-1795
6. Chernova O.B., et al. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol. Cell. Biol. 18 (1998) 536-545
7. Coquelle A., et al. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89 (1997) 215-225
8. Kuo M.T., et al. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol. Cell. Biol. 14 (1994) 5202-5211
9. Paulson T.G., et al. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol. Cell. Biol. 18 (1998) 3089-3100
10. Pipiras E., et al. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J. 17 (1998) 325-333
11. Difilippantonio M.J., et al. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196 (2002) 469-480
12. Zhu C., et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109 (2002) 811-821
13. Bautista S., and Theillet C. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Genes Chromosomes Cancer 22 (1998) 268-277
14. Guan X.Y., et al. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat. Genet. 8 (1994) 155-161
15. Lafage M., et al. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line. Genes Chromosomes Cancer 5 (1992) 40-49
16. Muleris M., et al. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes Chromosomes Cancer 14 (1995) 155-163
17. Brown L.A., et al. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol. Oncol. 100 (2006) 246-270
18. Snijders A.M., et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24 (2005) 4232-4242
19. Albertson D.G., et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25 (2000) 144-146
20. Varshavsky A. On the possibility of metabolic control of replicon 'misfiring': relationship to emergence of malignant phenotypes in mammalian cell lineages. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 3673-3677
21. Schimke R.T., et al. Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 2157-2161
22. Windle B.E., and Wahl G.M. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat. Res. 276 (1992) 199-224
23. Savelyeva L., and Schwab M. Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett. 167 (2001) 115-123
24. Vogt N., et al. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11368-11373
25. Kuwahara Y., et al. Alternative mechanisms of gene amplification in human cancers. Genes Chromosomes Cancer 41 (2004) 125-132
26. Londono-Vallejo J.A. Telomere length heterogeneity and chromosome instability. Cancer Lett. 212 (2004) 135-144
27. Sabatier L., et al. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol. Cancer Res. 3 (2005) 139-150
28. O'Hagan R.C., et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2 (2002) 149-155
29. Chang S., et al. Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol. 11 (2001) 227-239
30. Maser R.S., and DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 297 (2002) 565-569
31. Gisselsson D., et al. Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma. Genes Chromosomes Cancer 42 (2005) 22-33
32. Gisselsson D., and Hoglund M. Connecting mitotic instability and chromosome aberrations in cancer - can telomeres bridge the gap?. Semin. Cancer Biol. 15 (2005) 13-23
33. McClintock B. The fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl. Acad. Sci. U. S. A. 28 (1942) 458-463
34. Murnane J.P., and Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26 (2004) 1164-1174
35. Wahl G.M., et al. Effect of chromosomal position on amplification of transfected genes in animal cells. Nature 307 (1984) 516-520
36. Glover, T.W. et al. (2005) Mechanisms of common fragile site instability. Hum. Mol. Genet. 14 Spec No. 2, R197-205
37. Coquelle A., et al. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2 (1998) 259-265
38. Ciullo M., et al. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum. Mol. Genet. 11 (2002) 2887-2894
39. Hellman A., et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1 (2002) 89-97
40. Miller C.T., et al. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25 (2006) 409-418
41. Snijders A.M., et al. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 22 (2003) 4370-4379
42. Curtin J.A., et al. Distinct sets of genetic alterations in melanoma. New Engl. J. Med. 353 (2005) 2135-2147
43. Huang X., et al. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11369-11374
44. Johnson N. Tobacco use and oral cancer: a global perspective. J. Dent. Educ. 65 (2001) 328-339
45. Terry P.D., and Rohan T.E. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 953-971
46. Kao-Shan C.S., et al. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res. 47 (1987) 6278-6282
47. Rajagopalan H., and Lengauer C. Aneuploidy and cancer. Nature 432 (2004) 338-341
48. van Beers E.H., et al. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. 65 (2005) 822-827
49. Mottolese M., et al. Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer. J. Cell. Physiol. 204 (2005) 106-112
50. Roh H.J., et al. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res. 60 (2000) 6496-6502
51. Bastian B.C., et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 60 (2000) 1968-1973
52. Al-Kuraya K., et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64 (2004) 8534-8540
53. Paris P.L., et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum. Mol. Genet. 13 (2004) 1303-1313
54. Giulotto E., et al. Hamster cells with increased rates of DNA amplification, a new phenotype. Cell 48 (1987) 837-845
55. Mondello C., et al. Gene amplification in Chinese hamster DNA repair deficient mutants. Mutat. Res. 346 (1995) 61-67
56. Mondello C., et al. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res. 61 (2001) 4520-4525
57. Smith K.A., et al. Regulation and mechanisms of gene amplification. Philos. Trans. R. Soc. Lond. B Biol. Sci. 347 (1995) 49-56
58. Dini G., et al. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. J. Cell. Physiol. 193 (2002) 64-72
59. Huang A., et al. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. Cancer Res. 57 (1997) 4876-4881
60. Zhou P., et al. Overexpression of cyclin D1 enhances gene amplification. Cancer Res. 56 (1996) 36-39
61. Peterson C., et al. Mutations in RAD3, MSH2, and RAD52 affect the rate of gene amplification in the yeast Saccharomyces cerevisiae. Environ. Mol. Mutagen. 36 (2000) 325-334
62. Bassing C.H., and Alt F.W. The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst.) 3 (2004) 781-796
63. Blegen H., et al. DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis. Anal. Cell. Pathol. 25 (2003) 103-114
64. Weinstein I.B. Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science 297 (2002) 63-64
65. Mass R.D., et al. Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin. Breast Cancer 6 (2005) 240-246
66. Gorlick R., et al. Intrinsic and acquired resistance to methotrexate in acute leukemia. New Engl. J. Med. 335 (1996) 1041-1048
67. Wang T.L., et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3089-3094
68. Gorre M.E., et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293 (2001) 876-880
69. Giaccone G., and Rodriguez J.A. EGFR inhibitors: what have we learned from the treatment of lung cancer?. Nat. Clin. Pract. Oncol. 2 (2005) 554-561
70. Kaye F.J. A curious link between epidermal growth factor receptor amplification and survival: effect of 'allele dilution' on gefitinib sensitivity?. J. Natl. Cancer Inst. 97 (2005) 621-623
71. Nagase H., et al. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res. 63 (2003) 4849-4853
72. Zhang Z., et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29 (2001) 25-33
73. Pinkel D., and Albertson D.G. Comparative genomic hybridization. Annu. Rev. Genomics Hum. Genet. 6 (2005) 331-354
74. Pinkel D., and Albertson D.G. Array comparative genomic hybridization and its applications in cancer. Nat. Genet. 37 Suppl. (2005) S11-S17
75. Birchall P.S., et al. Expression patterns of predicted genes from the C. elegans genome sequence visualized by FISH in whole organisms. Nat. Genet. 11 (1995) 314-320
76. Speicher M.R., and Carter N.P. The new cytogenetics: blurring the boundaries with molecular biology. Nat. Rev. Genet. 6 (2005) 782-792
77. Wang T.L., et al. Digital karyotyping. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16156-16161
78. Ginzinger D.G., et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 60 (2000) 5405-5409
79. Volik S., et al. End-sequence profiling: sequence-based analysis of aberrant genomes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7696-7701
80. Tlsty T.D., et al. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 9441-9445
81. Smith K.A., et al. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1816-1821
82. Alt F.W., et al. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J. Biol. Chem. 253 (1978) 1357-1370
83. Pinkel D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20 (1998) 207-211
84. Fridlyand J., et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6 (2006) 96